{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:28:02Z","timestamp":1787138882620,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcjd.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:47:06Z","timestamp":1776354426000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Current Role and Clinical Impact of Continuous Glucose Monitoring on Canadian Adults Living With Type 2 Diabetes"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-9396","authenticated-orcid":false,"given":"Jeremy","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-7010","authenticated-orcid":false,"given":"Sonja M.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Cadieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2026.04.007_bib1","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc06-2544","article-title":"Effect of BMI on lifetime risk for diabetes in the U.S","volume":"30","author":"Narayan","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib2","first-page":"S167","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of care in diabetes---2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib4","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","article-title":"Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring","volume":"107","author":"Yapanis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jcjd.2024.08.002","article-title":"Pharmacologic glycemic management of type 2 diabetes in adults---2024 update","volume":"48","author":"Shah","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2026.04.007_bib6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcjd.2023.09.001","article-title":"Factors associated with attainment of glycemic targets among adults with type 1 and type 2 diabetes in Canada: A cross-sectional study using primary and specialty care electronic medical record data","volume":"48","author":"Weisman","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2026.04.007_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: How using HbA(1c) alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib9","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc18-1150","article-title":"Clinical implications of real-time and intermittently scanned continuous glucose monitoring","volume":"41","author":"Edelman","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib10","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1111\/dom.70008","article-title":"Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials","author":"Aronson","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","article-title":"Continuous glucose monitoring for the routine care of type 2 diabetes mellitus","volume":"20","author":"Ajjan","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib12","first-page":"S83","article-title":"Glycemic targets: Standards of medical care in diabetes---2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib15","first-page":"183","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes---2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib16","first-page":"S181","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes---2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","article-title":"Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: A systematic review of randomised controlled trials and meta-analysis","volume":"65","author":"Teo","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2026.04.007_bib18","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2026.04.007_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA---a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib20","first-page":"S132","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of care in diabetes---2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: A systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2026.04.007_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/193229681100500320","article-title":"The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus","volume":"5","author":"Ehrhardt","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2026.04.007_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211067418","article-title":"Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register","volume":"20","author":"Eeg-Olofsson","year":"2023","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jcjd.2026.04.007_bib24","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2026.04.007_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-024-06289-z","article-title":"Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies","volume":"68","author":"Nathanson","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2026.04.007_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13300-019-00741-9","article-title":"Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes","volume":"11","author":"Kr\u00f6ger","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib28","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s13300-024-01629-z","article-title":"Flash glucose monitoring is associated with HbA1c improvement in type 2 diabetes managed with multiple daily injections of insulin in the UK: A retrospective observational study","volume":"15","author":"Adamson","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211021374","article-title":"The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study","volume":"18","author":"Elliott","year":"2021","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jcjd.2026.04.007_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002590","article-title":"Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: A retrospective real-world chart review study and meta-analysis","volume":"10","author":"Carlson","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111899","article-title":"The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial","volume":"217","author":"Lau","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2026.04.007_bib32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/dom.16116","article-title":"Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non-insulin therapies---A randomised controlled trial","volume":"27","author":"Semmondo","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib33","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s13300-024-01619-1","article-title":"Association of changes in A1C following continuous glucose monitoring acquisition in people with sub-optimally treated type 2 diabetes taking GLP-1 RA therapy","volume":"15","author":"Miller","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/jcm13030642","article-title":"Effectiveness and safety of the intermittently scanned continuous glucose monitoring system FreeStyle Libre 2 in patients with type 2 diabetes treated with basal insulin or oral antidiabetic drugs: An observational, retrospective real-world study","volume":"13","author":"Conti","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcjd.2026.04.007_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-83548-4","article-title":"Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care","volume":"14","author":"Shields","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjd.2026.04.007_bib36","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1111\/dom.16266","article-title":"FRONTIER: FReeStyle Libre system use in Ontario among people with diabetes in the IC\/ES database-Evidence from real-world practice: Patients on basal insulin, glucagon-like peptide 1 receptor agonist or oral therapies","volume":"27","author":"Ratzki-Leewing","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1089\/dia.2024.0015","article-title":"Initiating GLP-1 therapy in combination with FreeStyle Libre provides greater benefit compared with GLP-1 therapy alone","volume":"26","author":"Wright","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/ds20-0069","article-title":"Use of flash continuous glucose monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy","volume":"34","author":"Wright","year":"2021","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.jcjd.2026.04.007_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/dc22-1219","article-title":"Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: Results of the LIBERATES trial","volume":"46","author":"Ajjan","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/dc23-2194","article-title":"Comparing continuous glucose monitoring and blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes (Steno2tech Study): A 12-month, single-center, randomized controlled trial","volume":"47","author":"Lind","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib42","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2337\/dc21-1304","article-title":"The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin","volume":"44","author":"Aleppo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/dia.2021.0489","article-title":"Magnitude of glycemic improvement in patients with type 2 diabetes treated with basal insulin: Subgroup analyses from the MOBILE Study","volume":"24","author":"Davis","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/dia.2024.0197","article-title":"Long-term improvements in glycemic control with Dexcom CGM use in adults with noninsulin-treated type 2 diabetes","volume":"26","author":"Layne","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/dom.14949","article-title":"IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial","volume":"25","author":"Aronson","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib46","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/dom.15608","article-title":"Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial","volume":"26","author":"Reed","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2026.04.007_bib47","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1111\/dom.15866","article-title":"Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: Real-world analysis","volume":"26","author":"Garg","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl.","key":"10.1016\/j.jcjd.2026.04.007_bib48","first-page":"S21","article-title":"Impact of continuous glucose monitoring on emergency department visits and all-cause hospitalization rates among Medicaid beneficiaries with type 2 diabetes treated with multiple daily insulin or basal insulin therapy","volume":"30","author":"Hirsch","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jcjd.2026.04.007_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/dia.2023.0034","article-title":"Reduced acute diabetes events after FreeStyle Libre system initiation in people 65 years or older with type 2 diabetes on intensive insulin therapy in France","volume":"25","author":"Guerci","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/dia.2022.0271","article-title":"Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre system initiation in people with type 2 diabetes on basal insulin therapy in France","volume":"25","author":"Guerci","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib51","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s12325-024-02851-8","article-title":"Reduction in diabetes-related hospitalizations and medical costs after Dexcom G6 continuous glucose monitor initiation in people with type 2 diabetes using intensive insulin therapy","volume":"41","author":"Hannah","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib52","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.37765\/ajmc.2021.88780","article-title":"Flash CGM associated with event reduction in nonintensive diabetes therapy","volume":"27","author":"Miller","year":"2021","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108106","article-title":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","volume":"36","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jcjd.2026.04.007_bib54","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2023-0075","article-title":"Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada","volume":"12","author":"Alshannaq","year":"2023","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jcjd.2026.04.007_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/dia.2021.0525","article-title":"Association between real-time continuous glucose monitor use and diabetes-related medical costs for patients with type 2 diabetes","volume":"24","author":"Norman","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib56","series-title":"Coverage of glucose monitoringdevices","year":"2025"},{"key":"10.1016\/j.jcjd.2026.04.007_bib68","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s13300-021-01086-y","article-title":"Episodic real-time CGM use in adults with type 2 diabetes: Results of a pilot randomized controlled trial","volume":"12","author":"Price","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/dia.2024.0406","article-title":"Impact of continuous glucose monitoring versus blood glucose monitoring to support a carbohydrate-restricted nutrition intervention in people with type 2 diabetes","volume":"27","author":"Willis","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/dme.70114","article-title":"Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams","volume":"42","author":"Olsen","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2026.04.007_bib71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc24-2222","article-title":"In-hospital diabetes management by a diabetes team and insulin titration algorithms based on continuous glucose monitoring or point-of-care glucose testing in patients with type 2 diabetes (DIATEC): A randomized controlled trial","volume":"48","author":"Olsen","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2026.04.007_bib72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1932296821998724","article-title":"Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care","volume":"15","author":"Simonson","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2026.04.007_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15348","article-title":"Real time continuous glucose monitoring in high-risk people with insulin-requiring type 2 diabetes: A randomised controlled trial","volume":"41","author":"Lever","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2026.04.007_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/dia.2021.0212","article-title":"Use of real-time continuous glucose monitoring improves glycemic control and other clinical outcomes in type 2 diabetes patients treated with less intensive therapy","volume":"24","author":"Grace","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2008.01.006","article-title":"Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial","volume":"80","author":"Allen","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2026.04.007_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/dia.2024.0579","article-title":"a randomized controlled trial using continuous glucose monitoring to guide food choices and diabetes self-care in people with type 2 diabetes not taking insulin","volume":"27","author":"Martens","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.007_bib58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/cd23-0077","article-title":"Detection and intervention: Use of continuous glucose monitoring in the early stages of type 2 diabetes","volume":"42","author":"Miller","year":"2024","journal-title":"Clin Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib57","article-title":"7-OR: The Libre Enabled Reduction of A1C through Effective Eating and Exercise Study---LIBERATE CANADA","volume":"74","author":"Reichert","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2026.04.007_bib59","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1177\/19322968221110830","article-title":"Use of continuous glucose monitors by people without diabetes: An idea whose time has come?","volume":"17","author":"Klonoff","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib60","article-title":"2018-LB: Stelo glucose biosensor use in people without diabetes, with prediabetes, or with non\u2013insulin treated type 2 diabetes over first 30 days","volume":"74","author":"Layne","year":"2025","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib61","article-title":"1326-P: Prediabetes---identifying the gaps in diagnosis and lifestyle intervention?","volume":"74","author":"Hannah","year":"2025","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib62","article-title":"2020-LB: Early experiences with Stelo---real-world behavioral and glycemic outcomes in users with type 2 diabetes, prediabetes, or no diabetes","volume":"74","author":"Crawford","year":"2025","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2026.04.007_bib63","article-title":"1852-LB: \u201cI realized that I could control my health with better eating habits and exercise\u201d---significant improvements in psychosocial health and lifestyle in people with prediabetes using Dexcom rtCGM","volume":"73","author":"Crawford","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2026.04.007_bib64","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eprac.2025.05.742","article-title":"Continuous glucose monitoring for prediabetes: Roles, evidence, and gaps","volume":"31","author":"Zahalka","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jcjd.2026.04.007_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13300-024-01677-5","article-title":"Cost-effectiveness of FreeStyle Libre for glucose self-management among people with diabetes mellitus: A Canadian private payer perspective","volume":"16","author":"Harris","year":"2025","journal-title":"Diabetes Ther"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:06:32Z","timestamp":1787137592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267126000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"alternative-id":["S1499267126000717"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.04.007","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Current Role and Clinical Impact of Continuous Glucose Monitoring on Canadian Adults Living With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published on behalf of Diabetes Canada.","name":"copyright","label":"Copyright"}]}}